The current valuation score of Capricor Therapeutics Inc is 8.47, ranking 129 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -12.25, which is -80.80% below the recent high of -2.35 and -74.93% above the recent low of -21.43.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.